Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

SubjectWell

Explore full profile

Risk-free patient recruitment for clinical trials

Austin, United StatesFounded 2012Biotech & Life Sciences
Valuation $100–250M Last recorded · 2022
Revenue $10–50M Latest reported FY
Headcount 100–500 Current team size
Total funding $50–100M Disclosed equity funding
Unlock exact values This page shows ranges. Dealroom has the exact numbers for SubjectWell and the history behind them.

About SubjectWell

SubjectWell is a startup that specializes in patient recruitment for clinical trials. The company operates in the healthcare and pharmaceutical sectors, serving clients such as pharmaceutical companies, biotech firms, and clinical research organizations. SubjectWell's primary service is to connect these clients with qualified patients who are willing to participate in clinical trials.

The company leverages real-time data to identify and refer patients who meet the specific criteria of a given study. This data-driven approach allows SubjectWell to deliver referrals at a much faster rate compared to traditional methods. Their "high touch" approach means they actively engage with patients, which results in higher randomization rates—patients who are more likely to be selected and participate in the trial.

SubjectWell's business model is performance-based, meaning clients only pay for patients who actually randomize into the clinical trial. This reduces financial risk for their clients, as they are not paying upfront for uncertain outcomes. The company offers a risk-free assessment to potential clients, using real-world data to estimate how many qualified patients they can recruit for a specific study. This customized analysis helps clients understand how quickly they can meet their enrollment goals.

In summary, SubjectWell accelerates the patient recruitment process for clinical trials, providing a cost-effective and efficient solution for their clients. By focusing on real-time data and a performance-based payment model, they minimize financial risk and maximize the likelihood of successful patient enrollment.

Source: Dealroom company data

At a glance

Founded
2012
Headquarters
Austin, United States
Sector
Biotech & Life Sciences
Power Law
Colt$25–100M revenue

Investors

5 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Seed1 investor entered at this stage

  • Healthy Ventures

Series A3 investors entered at this stage

  • Windham Venture Partners
  • Geekdom Fund
  • Asset Management Ventures

Series B and later1 investor entered at this stage

  • WindRose Health Investors
Employees mapped 140 incl. 3 AI specialists
Founders Hidden — book a demo/100 quality score
Key operators 25 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
9 countries with
team presence
🇿🇦 South Africa54.4%
🇺🇸 United States32.6%
🇩🇪 Germany8.7%
🇳🇱 Netherlands0.7%
🇮🇹 Italy0.7%
Top 5 of 9 shown
Web traffic by country
13K monthly visits
across markets
🇿🇦 South Africa46.9%
🇺🇸 United States45.4%
🇮🇳 India5.4%
🇬🇧 United Kingdom4.6%
🇵🇱 Poland0.8%
Top 5 markets shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about SubjectWell on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See SubjectWell on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.